Fusako Sakai-Takemura

Prostaglandin EP2 receptor downstream of Notch signaling inhibits differentiation of human skeletal muscle progenitors in differentiation conditions

S. Takeda, N. Hashimoto, Y. Miyagoe-Suzuki, 2020, Communications Biology.

Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors

S. Takeda, S. Masuda, Y. Miyagoe-Suzuki, 2018, Scientific Reports.

iNOS is not responsible for nitrosylation of RyR1 in mdx mice with truncated dystrophin

J. Kira, S. Takeda, J. Tanihata, 2020 .

iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin

J. Kira, S. Takeda, J. Tanihata, 2020, BMC Musculoskeletal Disorders.

Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR)

S. Takeda, Y. Miyagoe-Suzuki, Fusako Sakai-Takemura, 2021, Stem Cell Research & Therapy.

iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin

J. Kira, S. Takeda, J. Tanihata, 2020, BMC Musculoskeletal Disorders.

Prostaglandin EP2 receptor downstream of Notch signaling inhibits differentiation of human skeletal muscle progenitors in differentiation conditions

S. Takeda, N. Hashimoto, Y. Miyagoe-Suzuki, 2020, Communications Biology.

Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice

J. Kira, S. Takeda, Y. Aoki, 2021, Human molecular genetics.

Mesenchymal Stem Cells for Regenerative Medicine for Duchenne Muscular Dystrophy

S. Takeda, Y. Miyagoe-Suzuki, Fusako Sakai-Takemura, 2020, Muscular Dystrophy - Research Updates and Therapeutic Strategies.

Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors

S. Takeda, S. Masuda, Y. Miyagoe-Suzuki, 2018, Scientific Reports.